{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:06:28Z","timestamp":1789653988030,"version":"4.0.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01477-x","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:24:19Z","timestamp":1783088659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1\u00a0A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418"],"prefix":"10.1186","volume":"16","author":[{"given":"Adam J","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Sandiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-0208","authenticated-orcid":false,"given":"Paul","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Tauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole","family":"Daegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger N","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Madonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"11","key":"1477_CR1","doi-asserted-by":"publisher","first-page":"eaba1187","DOI":"10.1126\/sciadv.aba1187","volume":"7","author":"R Baba","year":"2021","unstructured":"Baba R, Matsuda S, Arakawa Y, Yamada R, Suzuki N, Ando T, Oki H, Igaki S, Daini M, Hattori Y, Matsumoto S, Ito M, Nakatani A, Kimura H. LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models. Sci Adv. 2021;7(11):eaba1187.","journal-title":"Sci Adv"},{"issue":"7","key":"1477_CR2","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1021\/acs.jmedchem.0c01937","volume":"64","author":"Y Hattori","year":"2021","unstructured":"Hattori Y, Matsuda S, Baba R, Matsumiya K, Iwasaki S, Constantinescu CC, Morley TJ, Carroll VM, Papin C, Gouasmat A, Alagille D, Tamagnan G, Koike T. Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain. J Med Chem. 2021;64(7):3780\u201393.","journal-title":"J Med Chem"},{"issue":"1","key":"1477_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-025-56985-6","volume":"16","author":"MA Hossain","year":"2025","unstructured":"Hossain MA, Brahme RR, Miller BC, Amin J, de Barros M, Schneider JL, Auclair JR, Mattos C, Wang Q, Agar NYR, Greenblatt DJ, Manetsch R, Agar JN. Mass spectrometry methods and mathematical PK\/PD model for decision tree-guided covalent drug development. Nat Commun. 2025;16(1):1777.","journal-title":"Nat Commun"},{"issue":"8","key":"1477_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2217\/epi-2016-0009","volume":"8","author":"A Maiques-Diaz","year":"2016","unstructured":"Maiques-Diaz A, Somervaille TC. LSD1: biologic roles and therapeutic targeting. Epigenomics. 2016;8(8):1103\u201316.","journal-title":"Epigenomics"},{"issue":"17","key":"1477_CR5","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1021\/acs.jmedchem.1c00653","volume":"64","author":"S Matsuda","year":"2021","unstructured":"Matsuda S, Hattori Y, Matsumiya K, McQuade P, Yamashita T, Aida J, Sandiego CM, Gouasmat A, Carroll VM, Barret O, Tamagnan G, Koike T, Kimura H. Design, Synthesis, and Evaluation of [18F]T-914 as a Novel Positron-Emission Tomography Tracer for Lysine-Specific Demethylase 1. J Med Chem. 2021;64(17):12680\u201390.","journal-title":"J Med Chem"},{"issue":"2","key":"1477_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/cn200104y","volume":"3","author":"R Neelamegam","year":"2012","unstructured":"Neelamegam R, Ricq EL, Malvaez M, Patnaik D, Norton S, Carlin SM, Hill IT, Wood MA, Haggarty SJ, Hooker JM. Brain-penetrant LSD1 inhibitors can block memory consolidation. ACS Chem Neurosci. 2012;3(2):120\u20138.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1477_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13550-025-01350-3","volume":"16","author":"Y Petibon","year":"2025","unstructured":"Petibon Y, Takano A, Schwarz AJ, Yardibi O, Sandiego C, Barret O, Constantinescu C, Tauscher J, McQuade P. Evaluation of [18F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1A (LSD1), in non-human primates. EJNMMI Res. 2025;16(1):8. https:\/\/doi.org\/10.1186\/s13550-025-01350-3.","journal-title":"EJNMMI Res"},{"issue":"1","key":"1477_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0962280214537344","volume":"24","author":"DL Raunig","year":"2015","unstructured":"Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, G\u00f6nen M, Zahlmann G, Kondratovich MV, O\u2019Donnell K, Petrick N, Cole PE, Garra B, Sullivan DC. QIBA Technical Performance Working Group. Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res. 2015;24(1):27\u201367.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"1477_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.euroneuro.2009.10.005","volume":"20","author":"J Tauscher","year":"2010","unstructured":"Tauscher J, Kielbasa W, Iyengar S, Vandenhende F, Peng X, Mozley D, Gehlert DR, Marek G. Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder. Eur Neuropsychopharmacol. 2010;20(2):80\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"1477_CR10","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1111\/bcp.14912","volume":"87","author":"W Yin","year":"2021","unstructured":"Yin W, Arkilo D, Khudyakov P, Hazel J, Gupta S, Quinton MS, Lin J, Hartman DS, Bednar MM, Rosen L, Wendland JR. Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A. Br J Clin Pharmacol. 2021;87(12):4756\u201368.","journal-title":"Br J Clin Pharmacol"},{"key":"1477_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.omtm.2021.02.011","volume":"20","author":"L Zhang","year":"2021","unstructured":"Zhang L, Pilarowski G, Pich EM, Nakatani A, Dunlop J, Baba R, Matsuda S, Daini M, Hattori Y, Matsumoto S, Ito M, Kimura H, Bjornsson HT. Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome. Mol Ther Methods Clin Dev. 2021;20:779\u201391.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01477-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:52:24Z","timestamp":1789653144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01477-x","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both studies were approved by the Advarra institutional review board (IRB) and all participants gave informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publication of deidentified data was included in the informed consent.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AJS, AT, PM, TB and JT are or were employees of Takeda at the time of the study and may own company stock. CMS, CC, ND, KM, RNG, JM and DSR were employees of Invicro LLC at the time of the study. No other potential conflict of interest relevant to this article is reported.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"135"}}